Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Curatively intended surgery for exocrine pancreatic cancer

Andrén-Sandberg, A. LU and Hafström, A. LU (1994) In The Gastroenterologist 2(1). p.20-26
Abstract

Resective surgery for exocrine pancreatic cancer can currently be performed with little or no hospital mortality. The operation is most often performed as a Whipple resection, but several modifications (e.g., subtotal pancreatectomy) have been advocated. The pylorus-preserving modification has gained in popularity, although its ability to remove all lymph nodes has been questioned. Total pancreatectomy, always causing brittle diabetes, is performed in less than 10% of patients, and then more and more often as part of an extended operation, including major vessels, which must be substituted. Adjuvant treatment with impact on long-term survival is lacking; however, the results of curatively intended surgery for exocrine pancreatic cancer... (More)

Resective surgery for exocrine pancreatic cancer can currently be performed with little or no hospital mortality. The operation is most often performed as a Whipple resection, but several modifications (e.g., subtotal pancreatectomy) have been advocated. The pylorus-preserving modification has gained in popularity, although its ability to remove all lymph nodes has been questioned. Total pancreatectomy, always causing brittle diabetes, is performed in less than 10% of patients, and then more and more often as part of an extended operation, including major vessels, which must be substituted. Adjuvant treatment with impact on long-term survival is lacking; however, the results of curatively intended surgery for exocrine pancreatic cancer is slowly getting better.

(Less)
Please use this url to cite or link to this publication:
author
and
publishing date
type
Contribution to journal
publication status
published
in
The Gastroenterologist
volume
2
issue
1
pages
7 pages
publisher
Little Brown & Co
external identifiers
  • pmid:7914459
  • scopus:0028398987
ISSN
1065-2477
language
English
LU publication?
no
id
ba1df31c-adcd-4315-8c85-166c4e1ff457
date added to LUP
2020-05-09 08:37:41
date last changed
2024-01-02 10:56:27
@article{ba1df31c-adcd-4315-8c85-166c4e1ff457,
  abstract     = {{<p>Resective surgery for exocrine pancreatic cancer can currently be performed with little or no hospital mortality. The operation is most often performed as a Whipple resection, but several modifications (e.g., subtotal pancreatectomy) have been advocated. The pylorus-preserving modification has gained in popularity, although its ability to remove all lymph nodes has been questioned. Total pancreatectomy, always causing brittle diabetes, is performed in less than 10% of patients, and then more and more often as part of an extended operation, including major vessels, which must be substituted. Adjuvant treatment with impact on long-term survival is lacking; however, the results of curatively intended surgery for exocrine pancreatic cancer is slowly getting better.</p>}},
  author       = {{Andrén-Sandberg, A. and Hafström, A.}},
  issn         = {{1065-2477}},
  language     = {{eng}},
  month        = {{01}},
  number       = {{1}},
  pages        = {{20--26}},
  publisher    = {{Little Brown & Co}},
  series       = {{The Gastroenterologist}},
  title        = {{Curatively intended surgery for exocrine pancreatic cancer}},
  volume       = {{2}},
  year         = {{1994}},
}